RSV (Respiratory Syncytial Virus)
Participate in clinical trials for RSV (Respiratory Syncytial Virus) to support vital research aimed at developing innovative treatments and improving care. Your involvement helps enhance outcomes and quality of life for individuals affected by RSV. Join us today to make a meaningful difference!
Showing all 2 results
-
Pediatric Respiratory Syncytial Virus (RSV)
We’re conducting a study to explore a new option for children with respiratory syncytial virus (RSV). This research aims to better understand how it can support recovery and overall health. Criteria & Qualifications: • Must be under 18 years old. • Diagnosed with RSV. • May have health factors like certain medical conditions. Compensation: Contact us for more information
Pediatric Respiratory Syncytial Virus (RSV)
Read more -
Respiratory Syncytial Virus (RSV)
We’re conducting a study to evaluate a new treatment for adults with acute respiratory syncytial virus (RSV) infection. The goal is to understand how this treatment may help reduce symptoms faster and improve health outcomes. Criteria & Qualifications: • Must be 18 years or older. • Diagnosed with acute RSV infection. • Exhibits risk factors such as age 60+, chronic lung diseases, or cardiovascular conditions. Compensation: Contact us for more information
Respiratory Syncytial Virus (RSV)
Read more